Christopher R. Hall

Christopher R. Hall

Saul Ewing LLP

Contact  |  View Bio  |  RSS

Latest Posts › Pharmaceutical

Share:

White Collar Watch - July 2014

In This Issue: - Move over Big Pharma: Health care is not the only industry susceptible to False Claims Act scrutiny - Third Circuit affirms dismissal of False Claims Act suit, citing contract...more

7/18/2014 - False Claims Act FDA GSA License Agreements Licenses Medicaid Medicare Medtronic Omnicare Pharmaceutical Software

Court Upholds Executive’s Conviction Stemming from Off-Label Drug Promotion

The U.S. Court of Appeals for the Ninth Circuit has upheld the wire fraud and misbranding convictions and sentence of InterMune Inc. founder W. Scott Harkonen. United States v. Harkonen, No. 11-10209 (9th Cir. March 4, 2013)....more

3/25/2013 - Commercial Speech FDCA InterMune Labeling Marketing Misbranding Off-Label Promotion Pharmaceutical Wire Fraud

Second Circuit Jettisons Criminal Conviction for Pharma Rep Convicted for Off-Label Promotion

On December 3, 2012, the United States Court of Appeals for the Second Circuit overturned the conviction of a pharmaceutical sales representative convicted for misbranding in violation of the federal Food, Drug and Cosmetic...more

12/20/2012 - FDCA First Amendment Misbranding Off-Label Promotion Pharmaceutical

3 Results
|
View per page
Page: of 1